NATURE’S SUNSHINE PRODUCTS, INC. Retained Earnings
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Retained Earnings of $85.58 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-06
- 2026-06-30: Retained Earnings (Accumulated Deficit) $85.58M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) $82.05M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) $76.93M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) $72.82M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2026-06-30 | $85.58M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $82.05M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $76.93M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $72.82M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $67.49M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $62.15M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $57.41M 10-K · filed 2026-03-10 |
| 2024-09-30 | $57.73M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $53.38M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $52.03M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $49.71M 10-K · filed 2025-03-11 |
| 2023-09-30 | $40.75M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $37.92M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $35.49M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $34.63M 10-K · filed 2024-03-12 |
| 2022-09-30 | $32.68M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $32.59M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $32.08M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $35.02M 10-K · filed 2023-03-16 |
| 2021-09-30 | $21.59M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $16.73M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $10.19M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.03M 10-K · filed 2022-03-08 |
| 2020-09-30 | $20.16M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.41M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.66M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $4.69M 10-K · filed 2021-03-10 |
| 2019-09-30 | $3.69M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $2.37M 10-Q · filed 2019-08-09 |
| 2019-03-31 | -$315.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | -$2.07M 10-K · filed 2020-03-11 |
| 2018-09-30 | $844.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$653.00K 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$720.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | -$2.07M 10-K · filed 2019-03-08 |
| 2017-09-30 | $15.29M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $12.80M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $12.99M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $12.72M 10-K · filed 2018-03-16 |
| 2016-09-30 | $21.25M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $18.97M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $18.29M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $18.09M 10-K · filed 2017-03-14 |
| 2015-09-30 | $16.27M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $15.38M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $14.69M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $10.89M 10-K · filed 2016-03-14 |
| 2014-09-30 | $16.66M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $45.76M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $44.15M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $36.10M 10-K · filed 2015-03-13 |
| 2013-09-30 | $35.88M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $56.66M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $52.19M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $48.91M 10-K · filed 2014-03-17 |
| 2012-09-30 | $45.20M 10-Q · filed 2012-11-06 |
| 2012-06-30 | $39.61M 10-Q · filed 2012-08-03 |
| 2012-03-31 | $33.11M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $25.88M 10-K · filed 2013-03-07 |
| 2011-09-30 | $18.26M 10-Q · filed 2011-11-08 |
| 2011-06-30 | $20.51M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $8.28M 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |